Abstract |
We analysed the immunophenotypic and molecular expression of BCA-1 (B-cell-specific chemokine) and CXCR5 (BCA-1 receptor) in normal skin and different cutaneous lymphoproliferative disorders ( cutaneous T-cell lymphoma (CTCL); cutaneous B-cell lymphoma (CBCL); cutaneous B-cell pseudolymphoma (PCBCL)), with the aim of investigating their possible involvement in the pathogenesis of cutaneous B-cell disorders. BCA-1 and CXCR5 were constantly expressed in CBCL and PCBCL, but not in normal skin and CTCL. BCA-1 and CXCR5 were constantly coexpressed by CD22+ B-cells, while CD35+ follicular dendritic cells coexpressed BCA-1 in PCBCL cells only. In low grade CBCL, as compared with high grade CBCL, the intensity of CXCR5 expression on neoplastic CD22+ cells was lower than that of BCA-1. The image analysis of reverse transcriptase-polymerase chain reaction (RT-PCR) products showed a significant quantitative difference between PCBCL/low grade CBCL and high grade CBCL. The above findings, although only observed in a small series of patients, are in keeping with findings in MALT gastric and gastric MALT lymphomas, adding further evidence of the close similarities between CBCL and MALT lymphomas.
|
Authors | M Mori, C Manuelli, N Pimpinelli, B Bianchi, C Orlando, C Mavilia, P Cappugi, E Maggi, B Giannotti, M Santucci |
Journal | European journal of cancer (Oxford, England : 1990)
(Eur J Cancer)
Vol. 39
Issue 11
Pg. 1625-31
(Jul 2003)
ISSN: 0959-8049 [Print] England |
PMID | 12855271
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCL13 protein, human
- Chemokine CXCL13
- Chemokines, CXC
- RNA, Neoplasm
|
Topics |
- Base Sequence
- Chemokine CXCL13
- Chemokines, CXC
(metabolism)
- Humans
- Immunohistochemistry
- In Situ Hybridization
- Lymphoma, B-Cell
(metabolism)
- Lymphoma, T-Cell, Cutaneous
(metabolism)
- Molecular Sequence Data
- RNA, Neoplasm
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
(methods)
- Skin Neoplasms
(metabolism)
|